Biomarkers in Autism Spectrum Disorder: From Traditional Constraints to AI-Driven Horizons in Precision Medicine
DOI:
https://doi.org/10.58600/eurjther2832Keywords:
autism spectrum disorder, biomarkers, oxidative stress, inflammation, artificial intelligenceAbstract
Objective: The aim of this review is to comprehensively evaluate the potential of biomarkers in the diagnosis, prognosis, and individualized treatment of Autism Spectrum Disorder (ASD), considering its complex nature and current diagnostic limitations.
Methods: The article provides an updated literature review focusing on blood- and urine-based biomarkers (oxidative stress, inflammation, neurotransmitters, microbiome), neuroimaging, genetic, and physiological markers. It also examines key challenges, ethical considerations, and promising future directions such as artificial intelligence (AI)-assisted multi-omics data integration.
Results: Biomarkers measured in blood and urine (e.g., isoprostanes, 8-OHdG, and inflammatory cytokines) highlight the role of oxidative stress and chronic inflammation in ASD pathophysiology. Neuroimaging and genetic markers show promise for early risk identification and biological subtyping. However, most current studies suffer from small sample sizes, replication issues, and lack of standardization, limiting their clinical applicability.
Conclusion: Biomarker-based approaches hold promise for making ASD diagnosis more objective and for facilitating earlier intervention by reducing diagnostic delays. In the future, AI-driven multi-omics integration may provide deeper insights into ASD heterogeneity and support the development of personalized treatment strategies. Managing ethical concerns such as privacy and discrimination through a neurodiversity-oriented perspective will be crucial in this process.
References
Maenner MJ (2023) Prevalence and Characteristics of Autism Spectrum Disorder among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill Summ. 72:1–14. https://doi.org/10.15585/mmwr.mm6745a7
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC.
Ganz ML (2007) The Lifetime Distribution of the Incremental Societal Costs of Autism. Arch Pediatr Adolesc Med. 161:343–349. https://doi.org/10.1001/archpedi.161.4.343
Rogge N, Janssen J (2019) The Economic Costs of Autism Spectrum Disorder: A Literature Review. J Autism Dev Disord. 49:2873–2900. https://doi.org/10.1007/s10803-019-04014-z
Chen L, Shi XJ, Liu H, Mao X, Gui LN, Wang H, et al (2021) Oxidative Stress Marker Aberrations in Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis of 87 Studies (N=9109). Transl Psychiatry. 11:15. https://doi.org/10.1038/s41398-020-01135-3
Hughes H, Moreno R, Ashwood P (2023) Innate Immune Dysfunction and Neuroinflammation in Autism Spectrum Disorder (ASD). Brain Behav Immun. 108:245–254. https://doi.org/10.1016/j.bbi.2022.12.001
Mohammedsaeed W, Alharbi M (2025) Biochemical Markers as Predictors of Health Outcomes in Autism Spectrum Disorder: A Comprehensive Systematic Review and Meta-Analysis. J Mol Neurosci. 75:17. https://doi.org/10.1007/s12031-024-02306-3
Kuźniar-Pałka A (2025) The Role of Oxidative Stress in Autism Spectrum Disorder Pathophysiology, Diagnosis and Treatment. Biomedicines. 13:388. https://doi.org/10.3390/biomedicines13020388
Waligóra A, Waligóra S, Kozarska M, Damasiewicz-Bodzek A, Gorczyca P, Tyrpień-Golder K (2019) Zaburzenia Ze Spektrum Autyzmu (ASD)–Biomarkery Stresu Oksydacyjnego Oraz Cyklu Metylacji I Transsulfuracji. Psychiatr Pol. 53:771–788. https://doi.org/10.12740/pp/89948
El-Ansary A, Al-Ayadhi L (2012) Lipid Mediators in Plasma of Autism Spectrum Disorders. Lipids Health Dis. 11:160. https://doi.org/10.1186/1476-511X-11-160
Qasem H, Al-Ayadhi L, El-Ansary A (2016) Cysteinyl Leukotriene Correlated with 8-Isoprostane Levels as Predictive Biomarkers for Sensory Dysfunction in Autism. Lipids Health Dis. 15:130. https://doi.org/10.1186/s12944-016-0298-0
Ming X, Stein T, Brimacombe M, Johnson W, Lambert G, Wagner G (2005) Increased Excretion of a Lipid Peroxidation Biomarker in Autism. Prostaglandins Leukot Essent Fatty Acids. 73:379–384. https://doi.org/10.1016/j.plefa.2005.06.002
Kilicaslan F, Ayaydin H, Celik H, Kutuk MO, Kandemir H, Koyuncu I, et al (2019) Antineuronal Antibodies and 8-OHdG an Indicator of Cerebellar Dysfunction in Autism Spectrum Disorder: A Case–Control Study. Psychiatry Clin Psychopharmacol. 29:840–846. https://doi.org/10.1080/24750573.2019.1674241
Melnyk S, Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ, et al (2012) Metabolic Imbalance Associated with Methylation Dysregulation and Oxidative Damage in Children with Autism. J Autism Dev Disord. 42:367–377. https://doi.org/10.1007/s10803-011-1260-7
Alam R, Abdolmaleky HM, Zhou JR (2017) Microbiome, Inflammation, Epigenetic Alterations, and Mental Diseases. Am J Med Genet B Neuropsychiatr Genet. 174:651–660. https://doi.org/10.1002/ajmg.b.32567
Kern JK, Geier DA, Sykes LK, Geier MR (2016) Relevance of Neuroinflammation and Encephalitis in Autism. Front Cell Neurosci. 9:519. https://doi.org/10.3389/fncel.2015.00519
Zou T, Liu J, Zhang X, Tang H, Song Y, Kong X (2020) Autoantibody and Autism Spectrum Disorder: A Systematic Review. Res Autism Spectr Disord. 75:101568. https://doi.org/10.1016/j.rasd.2020.101568
Zhou X, Xu X, Li L, Jin Y, Wang Q, Wang X, et al (2025) The Effect of Anti-Inflammatory Dimethylmalonic Acid on the Neurobehavioral Phenotype of a Neonatal ASD Model Induced by Antiepileptic Valproic Acid. Biomedicines. 13:1765. https://doi.org/10.3390/biomedicines13071765
Porokhovnik L, Kostyuk S, Ershova E, Stukalov S, Veiko N, Korovina NY, et al (2016) The Maternal Effect in Infantile Autism: Elevated DNA Damage Degree in Patients and Their Mothers. Biochemistry (Mosc) Suppl B Biomed Chem. 10:322–326. https://doi.org/10.1134/s1990750816040041
Lv T, Wang M, Kui L, Wu J, Xiao Y (2025) Novel Inflammatory Biomarkers for Autism Spectrum Disorder Detected by Plasma Olink Proteomics. Children (Basel). 12:2010. https://doi.org/10.3390/children12020210
Afify M, Kamel A, Abdel-Hakeem M, Ali M (2025) Can Vasopressin Levels Predict Autism Spectrum Disorder Severity? A Case-Control Study. Egypt Pediatr Assoc Gaz. 73:47. https://doi.org/10.1186/s43054-025-00383-6
Havranek T, Bacova Z, Bakos J (2024) Oxytocin, GABA, and Dopamine Interplay in Autism. Endocr Regul. 58:105–114. https://doi.org/10.2478/enr-2024-0012
Marotta R, Risoleo MC, Messina G, Parisi L, Carotenuto M, Vetri L, et al (2020) The Neurochemistry of Autism. Brain Sci. 10:163. https://doi.org/10.3390/brainsci10030163
Kopcikova M, Raskova B, Belica I, Bakos J, Celusakova H, Chladna Z, et al (2024) The Relationship between Serum Thyroid Hormone Levels and Symptoms Severity in Young Children with Autism. Endocr Regul. 58(4):259–265. https://doi.org/10.2478/enr-2024-0031
Ding W, Xu Y, Ding W, Tang Q, Zhang B, Yuan Y, et al (2025) Research Progress on Melatonin, 5-HT, and Orexin in Sleep Disorders of Children with Autism Spectrum Disorder. Biomol Biomed. 25:525. https://doi.org/10.17305/bb.2024.11182
Cui J, Zhai Z, Wang S, Song X, Qiu T, Yu L, et al (2024) The Role and Impact of Abnormal Vitamin Levels in Autism Spectrum Disorders. Food Funct. 15:1099–1115. https://doi.org/10.1039/d3fo03735e
Pagan C, Delorme R, Callebert J, Goubran-Botros H, Amsellem F, Drouot X, et al (2014) The Serotonin-N-Acetylserotonin–Melatonin Pathway as a Biomarker for Autism Spectrum Disorders. Transl Psychiatry. 4:e479. https://doi.org/10.1038/tp.2014.120
Xie K, Sun Y, Li X, Yang S, Wang M, Zhang Y, et al (2024) Biomarkers and Pathways in Autism Spectrum Disorder: An Individual Meta-Analysis Based on Proteomic and Metabolomic Data. Eur Arch Psychiatry Clin Neurosci. 1–17. https://doi.org/10.1007/s00406-024-01922-9
Frye RE, Vassall S, Kaur G, Lewis C, Karim M, Rossignol D (2019) Emerging Biomarkers in Autism Spectrum Disorder: A Systematic Review. Ann Transl Med. 7:792. https://doi.org/10.21037/atm.2019.11.53
Liu J, Tan Y, Zhang F, Wang Y, Chen S, Zhang N, et al (2024) Metabolomic Analysis of Plasma Biomarkers in Children with Autism Spectrum Disorders. MedComm. 5:e488. https://doi.org/10.1002/mco2.488
Tang X, Ran X, Liang Z, Zhuang H, Yan X, Feng C, et al (2025) Screening Biomarkers for Autism Spectrum Disorder Using Plasma Proteomics Combined with Machine Learning Methods. Clin Chim Acta. 565:120018. https://doi.org/10.1016/j.cca.2024.120018
Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R (2024) Metabolomic Changes in Children with Autism. World J Clin Pediatr. 13:92737. https://doi.org/10.5409/wjcp.v13.i2.92737
Liu X, Sun X, Guo C, Huang ZF, Chen YR, Feng FM, et al (2024) Untargeted Urine Metabolomics and Machine Learning Provide Potential Metabolic Signatures in Children with Autism Spectrum Disorder. Front Psychiatry. 15:1261617. https://doi.org/10.3389/fpsyt.2024.1261617
Wang H, Ding L, Mao Zh, Du Y, Han Qm, Xu Jy, et al (2025) Metabolomic Analysis of Blood Spots in a Chinese Cohort with Autism Spectrum Disorders: A Pilot Study. Metab Brain Dis. 40:230. https://doi.org/10.1007/s11011-025-01635-5
Abuljadayel D, Alotibi A, Algothmi K, Basingab F, Alhazmi S, Almuhammadi A, et al (2024) Gut Microbiota of Children with Autism Spectrum Disorder and Healthy Siblings: A Comparative Study. Exp Ther Med. 28:430. https://doi.org/10.3892/etm.2024.12719
Bhusri B, Sutheeworapong S, Kittichotirat W, Kusonmano K, Thammarongtham C, Lertampaiporn S, et al (2025) Characterization of Gut Microbiota on Gender and Age Groups Bias in Thai Patients with Autism Spectrum Disorder. Sci Rep. 15:2587. https://doi.org/10.1038/s41598-025-98923-y
Ying J, Xu X, Zhou R, Chung AC, Ng SK, Fan X, et al (2025) The Gut Microbiota in Young Adults with High-Functioning Autism Spectrum Disorder and Its Performance as Diagnostic Biomarkers. Nutrients. 17:1748. https://doi.org/10.21203/rs.3.rs-5753373/v1
Xiao HL, Zhu H, Zeng TA, Xu F, Yu SH, Yang CJ (2025) Potential Similarities in Gut Microbiota Composition between Autism Spectrum Disorder and Neurotypical Siblings: Insights from a Comprehensive Meta-Analysis. Neuroscience. 567:172–181. https://doi.org/10.1016/j.neuroscience.2025.01.010
Młynarska E, Barszcz E, Budny E, Gajewska A, Kopeć K, Wasiak J, et al (2025) The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders. Nutrients. 17:1135. https://doi.org/10.3390/nu17071135
Zarimeidani F, Rahmati R, Mostafavi M, Darvishi M, Khodadadi S, Mohammadi M, et al (2025) Gut Microbiota and Autism Spectrum Disorder: A Neuroinflammatory Mediated Mechanism of Pathogenesis? Inflammation. 48:501–519. https://doi.org/10.1007/s10753-024-02061-y
Yu R, Hafeez R, Ibrahim M, Alonazi WB, Li B (2024) The Complex Interplay between Autism Spectrum Disorder and Gut Microbiota in Children: A Comprehensive Review. Behav Brain Res. 473:115177. https://doi.org/10.1016/j.bbr.2024.115177
Pagnozzi AM, Conti E, Calderoni S, Fripp J, Rose SE (2018) A Systematic Review of Structural MRI Biomarkers in Autism Spectrum Disorder: A Machine Learning Perspective. Int J Dev Neurosci. 71:68–82. https://doi.org/10.1016/j.ijdevneu.2018.08.010
Behrouzi A, Valles-Capetillo E, Kana RK (2025) An ALE Meta-Analysis of the Neural Evidence of Facial Emotion Processing in Autism. World J Biol Psychiatry. 26:74–91. https://doi.org/10.1080/15622975.2024.2446823
Gao L, Qiao S, Zhang Y, Zhang T, Lu H, Guo X (2025) Parsing the Heterogeneity of Brain Structure and Function in Male Children with Autism Spectrum Disorder: A Multimodal MRI Study. Brain Imaging Behav. 19:407–420. https://doi.org/10.1007/s11682-025-00978-y
Qiao J, Yan H, Wang Z, Zhang G, Xu G (2025) The Autism Spectrum Disorder Subtypes Identification Based on Features of Structural and Functional Coupling. J Autism Dev Disord. https://doi.org/10.1007/s10803-025-06931-8
Chauhan G, Meitei AJ, Khundrakpam B, Singh KJ, Alee NT (2025) Classification and Feature Selection of Autism Spectrum Disorder Using MRI Data: A Machine Learning Approach. J Technol Behav Sci. https://doi.org/10.1007/s41347-025-00500-7
Hankus M, Ochman-Pasierbek P, Brzozowska M, Striano P, Paprocka J (2025) Electroencephalography in Autism Spectrum Disorder. J Clin Med. 14:1882. https://doi.org/10.3390/jcm14061882
Wei R, Wang Y, Fang H, Guan L, Gao J, Xu X, et al (2025) Distinct Features of EEG Microstates in Autism Spectrum Disorder Revealed by Meta-Analysis: The Contribution of Individual Age to Heterogeneity across Studies. Front Psychiatry. 16:1531694. https://doi.org/10.3389/fpsyt.2025.1531694
Dede AJ, Xiao W, Vaci N, Cohen MX, Milne E (2025) Exploring EEG Resting State Differences in Autism: Sparse Findings from a Large Cohort. Mol Autism. 16:13. https://doi.org/10.1186/s13229-025-00647-3
Wang BM, Mills Z, Jones HF, Montgomery JM, Lee KY (2025) Presymptomatic Biological, Structural, and Functional Diagnostic Biomarkers of Autism Spectrum Disorder. J Neurochem. 169:e70088. https://doi.org/10.1111/jnc.70088/v2/response1
Wang F, Yang S, Xu J, Zuo J, Zou M, Sun C (2025) HCAR3 May Mediate Autism Symptoms: Evidence from RNA-Sequencing of Peripheral Blood Mononuclear Cells. Psychiatry Investig. 22(8):878-885. https://doi.org/10.30773/pi.2024.0377
Yao TT, Chen L, Du Y, Jiang ZY, Cheng Y (2025) MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder. Mol Neurobiol. 62:5039–5056. https://doi.org/10.1007/s12035-024-04582-x
Zhang Y, Chien WT, Chan JY-W, Cheung T-Y, He Z, Yip K-H, et al (2025) Optical Genome Mapping Reveals Novel Structural Variations in an Autism Spectrum Disorder Cohort. Comput Struct Biotechnol J. 27: 2233-2242. https://doi.org/10.1016/j.csbj.2025.05.043
Shan J, Gu Y, Zhang J, Hu X, Wu H, Yuan T, et al (2023) A Scoping Review of Physiological Biomarkers in Autism. Front Neurosci. 17:1269880. https://doi.org/10.3389/fnins.2023.1269880
Al-Mazidi S, Alhowikan A, Elamin N, Abualnaja A, Al-Mnaizel A, Alharbi T, et al (2025) Cognitive Function and Retinal Biomarkers as Novel Approach to Diagnosing and Assessing Autism Spectrum Disorder. Sci Rep. 15:17946. https://doi.org/10.1038/s41598-025-03062-z
Pérez-Jorge D, Olmos-Raya E, Alonso-Rodríguez I, Pérez-Pérez I, editors (2025) Electrodermal Response to Olfactory Stimuli in Children with Autism Spectrum Disorder: A Systematic Review of Emotional and Cognitive Regulation. Front Educ. 10:1485252. https://doi.org/10.3389/feduc.2025.1485252
Bazelmans T, Jones EJH, Ghods S, Corrigan S, Toth K, Charman T, et al (2019) Heart Rate Mean and Variability as a Biomarker for Phenotypic Variation in Preschoolers with Autism Spectrum Disorder. Autism Res. 12:39–52. https://doi.org/10.1002/aur.1982
Cheng YC, Huang YC, Huang WL (2020) Heart Rate Variability in Individuals with Autism Spectrum Disorders: A Meta-Analysis. Neurosci Biobehav Rev. 118: 463-471. https://doi.org/10.1016/j.neubiorev.2020.08.007
Tumedei M, Cenzato N, Panda S, Goker F, Del Fabbro M (2025) Salivary Biomarkers for Early Detection of Autism Spectrum Disorder: A Scoping Review. Oral. 5:56. https://doi.org/10.3390/oral5030056
Rossignol DA, Frye RE (2025) Early Biomarkers for Autism Spectrum Disorder Unveiled—What Are We Learning? Expert Rev Mol Diagn. . https://doi.org/10.1080/14737159.2025.2518143
McPartland JC (2016) Considerations in Biomarker Development for Neurodevelopmental Disorders. Curr Opin Neurol. 29:118–122. https://doi.org/10.1097/WCO.0000000000000300
Klin A (2018) Biomarkers in Autism Spectrum Disorder: Challenges, Advances, and the Need for Biomarkers of Relevance to Public Health. Focus (Madison). 16:135–142. https://doi.org/10.1176/appi.focus.20170047
Shaban WM (2025) Artificial Intelligence-Based Diagnostic Model for Autism Spectrum Disorder Using Blood Biomarkers. Neural Comput Appl. 37: 24075–24102. https://doi.org/10.1007/s00521-025-11553-3
Usta MB, Karabekiroglu K, Sahin B, Aydin M, Bozkurt A, Karaosman T, et al (2019) Use of Machine Learning Methods in Prediction of Short-Term Outcome in Autism Spectrum Disorders. Psychiatry Clin Psychopharmacol. 29:320–325. https://doi.org/10.1080/24750573.2018.1545334
Mehmetbeyoglu E, Duman A, Taheri S, Ozkul Y, Rassoulzadegan M (2023) From Data to Insights: Machine Learning Empowers Prognostic Biomarker Prediction in Autism. J Pers Med. 13:1713. https://doi.org/10.3390/jpm13121713
Nahas LD, Datta A, Alsamman AM, Adly MH, Al-Dewik N, Sekaran K, et al (2024) Genomic Insights and Advanced Machine Learning: Characterizing Autism Spectrum Disorder Biomarkers and Genetic Interactions. Metab Brain Dis. 39:29–42. https://doi.org/10.1007/s11011-023-01322-3
Appling C, Nuraini N, Holem R, Hunter S, Hirst K, Takahashi N, et al (2025) Cardiac Autonomic Measures Predict Clinician-Rated Anxiety and Behavioral Response to Propranolol in Autistic Children and Young Adults. J Pers Med. 15:286. https://doi.org/10.3390/jpm15070286
Climent-Pérez P, Martínez-González AE, Andreo-Martínez P (2024) Contributions of Artificial Intelligence to Analysis of Gut Microbiota in Autism Spectrum Disorder: A Systematic Review. Children. 11:931. https://doi.org/10.3390/children11080931
Topol EJ (2019) High-Performance Medicine: The Convergence of Human and Artificial Intelligence. Nat Med. 25:44–56. https://doi.org/10.1038/s41591-018-0300-7
Zhang-James Y, Buitelaar JK, ENIGMA‐ASD Working Group; van Rooij D, Faraone SV (2021) Ensemble classification of autism spectrum disorder using structural magnetic resonance imaging features. JCPP Adv. 6;1(3):e12042. https://doi.org/10.1002/jcv2.12042.
Li J, Wang F, Pan J, Wen Z (2021) Identification of Autism Spectrum Disorder With Functional Graph Discriminative Network. Front. Neurosci. 15:729937. https://doi.org/10.3389/fnins.2021.729937
Downloads
Published
How to Cite
License
Copyright (c) 2025 Berkan Şahin, Cansu Çobanoğlu Osmanlı
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
